Generic Curretab
Common uses: Curretab (Medroxyprogesterone) is a progestin used to treat menstrual disorders. Progestins lower the risk of estrogen-related cancer of the uterus. Curretab (Medroxyprogesterone) used in combination with estrogen (hormone replacement therapy - HRT) should not be used to prevent heart disease. A doctor may prescribe Curretab (Medroxyprogesterone) for additional conditions. More information about Curretab...
What is Generic Curretab?
Generic Curretab, like all generics, is the name given to the
prescription Medroxyprogesterone medication manufactured by any company other than the
original inventor of Curretab. The only true difference between brand name Curretab
and generic Curretab is that generic Curretab is always less expensive.
Other common names: Alti-MPA, Amen, Cycrin, Depo-Provera, Deviry, Gen-Medroxy, Lutoral, Medroxiprogesterona, Modus, Novo-Medrone, Provera, Medroxyprogesterone (generic name).
Generic Curretab , Medroxyprogesterone 1ml Disposable Syringe - Depo Provera, and Meprate - Medroxyprogesterone are at Freedom Pharmacy | *** SAVE 5% MORE WITH DISCOUNT CODE: MYN-05 *** | | Medication | Strength | Quantity | Price | Freedom Pharmacy | | Medroxyprogesterone - Provera | 2.5 mg | 30 tablets | $56.11 | Order | | Medroxyprogesterone - Provera | 2.5 mg | 90 tablets | $92.76 | Order | | Medroxyprogesterone - Provera | 5 mg | 100 tablets | $88.46 | Order | | Medroxyprogesterone - Provera | 5 mg | 200 tablets | $151.76 | Order | | Medroxyprogesterone - Provera | 10 mg | 30 tablets | $71.33 | Order | | Medroxyprogesterone - Provera | 10 mg | 90 tablets | $138.49 | Order | | Medroxyprogesterone - Provera | 100 mg | 30 tablets | $137.00 | Order | | Medroxyprogesterone 1ml Disposable Syringe - Depo Provera | 150 mg/ ml | 1ml | $83.94 | Order | | Medroxyprogesterone 1ml Disposable Syringe - Depo Provera | 150 mg/ ml | 3 x 1ml | $143.08 | Order | | Meprate - Medroxyprogesterone | 2.5 mg | 100 tablets | $67.92 | Order | | Meprate - Medroxyprogesterone | 2.5 mg | 200 | $93.86 | Order | | Meprate - Medroxyprogesterone | 2.5 mg | 400 | $125.34 | Order |
Generic Curretab made by Aca Müller/Adag Pharma, Depo Progevera manufactured by Pfizer, Depo Provera made by Docpharmvertrieb, Farlutal produced by Pfizer, Modus made by Almirall, Mpa by Hexal and Betapharm, Progevera produced by Pfizer, and Sayana made by Axicorp Pharma and Cc-Pharma are at Goldpharma | Medication | Strength | Quantity | Price | Goldpharma | | Depo Clinovir | 133.7 mg | 6 pre-filled syringe | $187.29 | Order | | Depo Progevera | 150 mg | 1 injection im | $9.23 | Order | | Depo Provera | 133.7 mg | 1 pre-filled syringe | $45.44 | Order | | Farlutal | 100 mg | 40 tablets | $42.19 | Order | | Modus | 30 mg | 30 tablets | $14.47 | Order | | Mpa | 222.8 mg | 20 tablets | $84.13 | Order | | Mpa | 222.8 mg | 50 tablets | $172.51 | Order | | Mpa | 222.8 mg | 100 tablets | $313.87 | Order | | Mpa | 445.6 mg | 20 tablets | $140.64 | Order | | Mpa | 445.6 mg | 50 tablets | $307.14 | Order | | Mpa | 445.6 mg | 100 tablets | $573.44 | Order | | Mpa Gyn | 4.46 mg | 30 tablets | $30.56 | Order | | Mpa Gyn | 4.46 mg | 60 tablets | $41.11 | Order | | Mpa Gyn | 4.46 mg | 100 tablets | $54.46 | Order | | Progevera | 5 mg | 24 tablets | $8.84 | Order | | Progevera | 250 mg | 60 tablets | $142.02 | Order | | Sayana | 92.7 mg | 1 suspension | $56.16 | Order | | Sayana | 92.7 mg | 6 pre-filled syringe | $227.79 | Order |
Generic Curretab is at Dokter Online | Medication | Strength | Quantity | Price | Dokter Online | | Provera | 5 mg | 30 tablets | $47.5 | Order | | Provera | 10 mg | 30 tablets | $53.5 | Order |
Buy Generic Curretab - No Prior Prescription Needed*
How To Buy Generic Curretab Online
Buy discount generic Curretab (Medroxyprogesterone) online by clicking on one of the low
prices shown. You'll be sent to our secure shopping cart where you can safely
complete your transaction.
Curretab - Health Bulletin
Tight Blood Sugar Control May Not Harm DiabeticsWEDNESDAY, April 28 (HealthDay News) -- The Action to Control Cardiovascular Risk in Diabetes (ACCORD) study was abruptly halted in 2008 when researchers noticed an increase in deaths in the group of type 2 diabetics who were being intensively treated to bring their blood sugar levels down to near-normal levels. Now, a new analysis of data from that study has concluded that a rapid lowering of blood sugar (glucose) levels was not the cause of the increased risk of mortality. Read entire article...
Please verify your local import regulations; the ability for a pharmacy to
offer a medication without a prescription does not negate any local requirement
you may have.
NOTICE: By using this site, you agree to verify and comply with your
country's rules and regulations should you undertake to purchase from any of
the listed pharmacies.
|
|
